(Total Views: 320)
Posted On: 03/06/2019 7:03:26 PM
Post# of 36566
And let me disseminate the correct info which is all in the public.... so this bashed is silenced
Excellagen has never been launched that’s why no $$$ world wide. Over $20 mill in development costs for R&D and they did not market it. We purchased the IP to commercialize it Worldwide except for China, Russia, and CIS. We have a very different Collagen pharmaceutical grade highly purified and clinical data to support the efficacy. The producers has been reviewed by the top wound care providers in the country. As far as the sentence “Excellagen should not be used with patients who have a known sensitivity to bovine collagen” well that’s a statement every drug has “ie if you have a known sensitivity to Penicillin do not take xyz”. Same with Aspirin etc. etc.
Excellagen has never been launched that’s why no $$$ world wide. Over $20 mill in development costs for R&D and they did not market it. We purchased the IP to commercialize it Worldwide except for China, Russia, and CIS. We have a very different Collagen pharmaceutical grade highly purified and clinical data to support the efficacy. The producers has been reviewed by the top wound care providers in the country. As far as the sentence “Excellagen should not be used with patients who have a known sensitivity to bovine collagen” well that’s a statement every drug has “ie if you have a known sensitivity to Penicillin do not take xyz”. Same with Aspirin etc. etc.
(1)
(0)
